Evidence map›Paper›PMID 36061422›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Efficient production of anthocyanins in

Sha Xu, Guangjian Li, Jingwen Zhou, Guicai Chen, Jianzhong Shao

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Enzyme promiscuity-driven co-production of flavonoid 7-Synthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Review
  5. De novo biosynthesis ofBiodesign research · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Screening ofSynthetic and systems biotechnology · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. A major facilitator superfamily transporter MdtH inApplied and environmental microbiology · 2024
    Article
  14. Identification ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sha XuCollege of Life Sciences, Key Laboratory for Cell and Gene Engineering of Zhejiang Province, Zhejiang University, Hangzhou, China.
Guangjian LiNational Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, China.
Jingwen ZhouNational Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, China.
Guicai ChenZhejiang Esigma Biotechnology Company Limited, Haining, China.
Jianzhong ShaoCollege of Life Sciences, Key Laboratory for Cell and Gene Engineering of Zhejiang Province, Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthocyanins are natural pigments found in various plants. As multifunctional natural compounds, anthocyanins are widely used in food, pharmaceuticals, health products, and cosmetics. At present, the anthocyanins are heterologously biosynthesized in prokaryotes from flavan-3-ols, which is rather expensive. This study aimed to metabolically engineer

Indexed as

anthocyaninsdegrading enzymede novo biosynthesisSaccharomyces cerevisiaetransporter

Identifiers

PMID36061422
PMCPMC9437251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.